Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001266003 | SCV001444175 | pathogenic | Inborn genetic diseases | 2019-10-16 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001781151 | SCV002019523 | pathogenic | not provided | 2019-08-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000000712 | SCV004293372 | pathogenic | Thrombophilia due to protein C deficiency, autosomal dominant | 2024-12-24 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 339 of the PROC protein (p.Val339Met). This variant is present in population databases (rs121918158, gnomAD 0.002%). This missense change has been observed in individual(s) with PROC-related conditions (PMID: 7670104, 25712501, 27081530). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is also known as p.Val297Met. ClinVar contains an entry for this variant (Variation ID: 677). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt PROC protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000000712 | SCV000020862 | pathogenic | Thrombophilia due to protein C deficiency, autosomal dominant | 1993-08-01 | no assertion criteria provided | literature only |